Literature DB >> 28427807

Targeted Next Generation Sequencing in patients with Myotonia Congenita.

Valentina Ferradini1, Marco Cassone1, Sara Nuovo1, Ilaria Bagni1, Maria Rosaria D'Apice1, Annalisa Botta1, Giuseppe Novelli1, Federica Sangiuolo2.   

Abstract

INTRODUCTION: Myotonia Congenita (MC) is a nondystrophic skeletal muscle disease characterized by muscle stiffness, weakness, delayed skeletal relaxation and hypertrophic muscle. The disease can be inherited as dominant or recessive. More than 130 mutations in CLCN1 gene have been identified.
MATERIALS AND METHODS: We analyzed the entire coding region and exon-intron boundaries of the CLCN1 gene in 40 MC patients. Samples already Sanger-sequenced were successively evaluated by Next Generation Sequencing (NGS), on Ion Torrent PGM. Moreover, additional 15 patients were sequenced directly by NGS.
RESULTS: NGS allowed us to identify all CLCN1 mutations except those located within exon 3, demonstrating a 96% of sensitivity. Due to primer design, one SNP (exactly rs7794560) also failed to be detected. Our results enlarge the spectrum of CLCN1 mutations and showed a novel approach for molecular analysis of MC.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Becker disease; CLCN1; Myotonia Congenita; NGS; Thomsen disease

Mesh:

Substances:

Year:  2017        PMID: 28427807     DOI: 10.1016/j.cca.2017.04.012

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Genetic spectrum and founder effect of non-dystrophic myotonia: a Japanese case series study.

Authors:  Jun-Hui Yuan; Yujiro Higuchi; Akihiro Hashiguchi; Masahiro Ando; Akiko Yoshimura; Tomonori Nakamura; Yusuke Sakiyama; Hiroshi Takashima
Journal:  J Neurol       Date:  2022-07-30       Impact factor: 6.682

2.  Evaluation of Cases with Myotonia Congenita for Cardiovascular Risk.

Authors:  Ibrahim Halil Damar; Recep Eroz
Journal:  Medeni Med J       Date:  2019-12-26

3.  Case report: Sodium and chloride muscle channelopathy coexistence: A complicated phenotype and a challenging diagnosis.

Authors:  Serena Pagliarani; Giovanni Meola; Melania Filareti; Giacomo Pietro Comi; Sabrina Lucchiari
Journal:  Front Neurol       Date:  2022-08-23       Impact factor: 4.086

4.  SCN4A as modifier gene in patients with myotonic dystrophy type 2.

Authors:  Anna Binda; Laura V Renna; Francesca Bosè; Elisa Brigonzi; Annalisa Botta; Rea Valaperta; Barbara Fossati; Ilaria Rivolta; Giovanni Meola; Rosanna Cardani
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.